<a href='https://www.finanznachrichten.de/nachrichten-aktien/biotricity-inc.htm' itemprop='url'> BIOTRICITY INC

Biotricity Inc.: Biotricity Delivers Strong Fiscal Year 2025 Results with Revenue Growth, Continued Margin Improvement, and Reduced Operating Expenses, Putting Profitability within Reach

FY25 revenue up 14.3% YOYFY25 margins improvement of 8.9% to 76.6%, from 69.3% in the prior year; Q4-FY25 margins improved to 80.4% as margin expansion forecasted to continueFY25 operating expenses...
► Artikel lesen

BIOTRICITY INC. - 10-K, Annual Report

Biotricity Inc.: Biotricity to Host Fiscal 2025 Fourth Quarter Financial Results and Business Update Call on July 18th

GlobeNewswire (USA)

01.07.

BIOTRICITY INC. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

08.04.

Biotricity Inc.: Biotricity Recognized by Financial Times as One of 2025's Fastest-Growing Companies in the Americas, Growing 256.4% Over the Period Analyzed

GlobeNewswire (USA)

BIOTRICITY Aktie jetzt für 0€ handeln

12.03.

Biotricity expands intellectual property portfolio with 14 new patents

12.03.

Biotricity Inc.: Biotricity Expands IP Portfolio & Strategy with 14 New Patents, Reinforcing Innovation & Leadership in Remote Monitoring, Diagnostics, & Chronic Disease Management

GlobeNewswire (USA)

21.02.

Biotricity GAAP EPS of -$0.05, revenue of $3.6M

20.02.

BIOTRICITY INC. - 10-Q/A, Quarterly Report

Biotricity Inc.: Biotricity Delivers Record Margins, Record Revenues, and Record Cashflows with 21.7% Year-Over-Year Sales Growth for its Third Quarter of Fiscal 2025

20.02.

153

Company reports Q3-FY25 revenue grew by 21.7% YOY to $3.6 millionManagement continues to drive revenues and efficienciesCompany achieved positive cash flow on current operating basis, before paying...
► Artikel lesen

19.02.

BIOTRICITY INC. - 10-Q, Quarterly Report

17.02.

Biotricity expects to post Q3 revenue growth of 22%, cashflow breakeven

Biotricity Inc.: Biotricity Announces Cashflow Breakeven with Biggest Quarter in History and a Revenue Increase of 11%

17.02.

157

Company expects to report Q3-FY25 revenue growth of 22% from the corresponding prior year quarter to $3.6 million - an 11% increase sequentially from the immediately preceding quarterManagement continues...
► Artikel lesen

14.02.

BIOTRICITY INC. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB

Biotricity Inc.: Biotricity Achieves Improved Margins and Efficiencies, and Year-Over-Year Sales Growth for Second Quarter of Fiscal Year 2025

15.11.24

175

Delisting of Securities of Gamer Pakistan Inc.; Biotricity, Inc.; Zalatoris II Acquisition Corp.; Warrantee Inc.; Spectaire Holdings, Inc.; Centogene N.V.; DZS Inc.; Corner Growth Acquisition Corp. 2; Collective Audience, Inc.; Grom ...

Company achieved positive cash flow in September on a current operating basis, before paying interest, dividends and amortization; management expects to continue to see cash flows improveCompany reports...
► Artikel lesen

10.10.24

664